Bnp Paribas Arbitrage, Snc »

Cue Biopharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2026-06-30 $35k 1.1k 31.56

More positions owned by Bnp Paribas Arbitrage, Snc

Micron Technology Equity (MU)
NVIDIA Corp Equity (NVDA)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)
Apple Equity (AAPL)
Microsoft Corp Equity (MSFT)
State Street SPDR S&P Biotech ETF Fund (XBI)
JPMorgan Chase & Co Equity (JPM)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Alphabet Equity (GOOG)
Broadcom Equity (AVGO)
Sandisk Corp Equity (SNDK)
iShares Russell 2000 ETF Fund (IWM)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma